一个新型钌(Ⅱ)配合物对F~-的双重光谱识别

采用紫外-可见光谱和荧光光谱滴定方法研究了钌(Ⅱ)配合物[Ru(bpy)(H2iip)2](ClO4)2[bpy=2,2'-联吡啶,H2iip=2-吲哚基-咪唑并[4,5-f][1,10]-邻菲罗啉]在DMSO溶液中对卤素离子的识别性质.结果表明该配合物能比色和荧光双重光谱高选择性识别F-.     

一种含吲哚咪唑基Ru(II)配合物的酸碱性质和与DNA相互作用的研究

合成了一个新的Ru(II)配合物[Ru(bpy)₂(H₂iip)](ClO₄)₂•5H₂O [bpy＝2,2'-联吡啶, H₂iip＝2-吲哚基-咪唑并[4,5-ƒ][1,10]-邻菲罗啉]. 通过酸碱滴定发射光谱测定了该配合物的表观电离常数; 用紫外可见光谱、荧光光谱、稳态荧光淬灭、溴化乙锭竞争键合、粘度测量和DNA裂解实验研究了配合物与DNA的相互作用性质. 结果表明配合物以经典的插入模式与DNA键合, 键合常数K_b＝(5.97±0.27)×10⁵ mol^－1•L (50 mmol/L NaCl).     

一种含吲哚咪唑基Ru(II)配合物的酸碱性质和与DNA相互作用的研究

合成了一个新的Ru(II)配合物[Ru(bpy)₂(H₂iip)](ClO₄)₂•5H₂O [bpy＝2,2'-联吡啶, H₂iip＝2-吲哚基-咪唑并[4,5-ƒ][1,10]-邻菲罗啉]. 通过酸碱滴定发射光谱测定了该配合物的表观电离常数; 用紫外可见光谱、荧光光谱、稳态荧光淬灭、溴化乙锭竞争键合、粘度测量和DNA裂解实验研究了配合物与DNA的相互作用性质. 结果表明配合物以经典的插入模式与DNA键合, 键合常数K_b＝(5.97±0.27)×10⁵ mol^－1•L (50 mmol/L NaCl).     

一种含芴基的钌(II)配合物的合成及DNA键合性质

合成了一种新的钌(II)配合物[Ru(bpy)2(Hfip)](ClO4)2, 其中bpy代表2,2′-联吡啶, Hfip代表2-(9H-芴-2-基)-1H-咪唑-[4,5-f]-[1,10]-邻菲啰啉. 通过紫外可见光谱、荧光光谱、稳态荧光淬灭、与溴化乙锭的竞争实验、粘度测量和DNA热变性研究了该配合物与小牛胸腺DNA的键合性质. 结果表明, 该配合物能嵌入键合DNA, 键合常数Kb=8.6×105 L·mol-1 (50 mmol·L-1 NaCl).     

1,2,4-苯三甲酸与2,2-联吡啶构筑的银(Ⅰ)和镉(Ⅱ)配合物的合成、晶体结构、热稳定性及荧光性质

通过pH调控的水热法合成了2种配合物[Ag(H2btc)(bpy)](1)和[Cd(Hbtc)(bpy)(H2O)2]n(2)(H3btc=1,2,4-苯三甲酸,bpy=2,2′-联吡啶),并通过X射线单晶衍射、红外光谱、热重分析、荧光光谱进行了表征与性质研究。结果表明,配合物1为零维的单核小分子结构,配合物2为一维的链状结构。荧光研究表明,这2种配合物均具有荧光性质。     

钌（Ⅱ）多吡啶配合物的合成、荧光性质及与脱氧核糖核酸DNA的作用机制研究

设计合成含多个配位中心的多吡啶配体ODCIP(3,4-二氯基苯并咪唑并[4,5-f][1,10]邻菲咯啉)及其钌(Ⅱ)多吡啶配合物[Ru(bpy)2ODCIP]2 .运用元素分析、红外光谱、核磁谱和质谱对配体及配合物进行结构表征.利用紫外吸收光谱、荧光光谱和粘度法研究了[Ru(bpy)2ODCIP]2 与DNA(脱氧核糖核酸)的作用机制、与Co2 配位后与DNA的作用机制及其荧光变化情况.结果表明[Ru(bpy)2ODCIP]2 与DNA通过部分插入模式作用,[Ru(bpy)2ODCIP]2 与Co2 配位形成的双核配合物[Ru(bpy)2(ODCIP)Co]4 也能与DNA插入结合.进一步利用稳态荧光发射光谱、荧光淬灭实验等方法研究了单核配合物[Ru(bpy)2ODCIP]2 和双核配合物[Ru(bpy)2(ODCIP)Co]4 的荧光性质.     

钌(II)多吡啶配合物的合成、荧光性质及与脱氧核糖核酸DNA的 作用机制研究

设计合成含多个配位中心的多吡啶配体ODCIP (3,4-二氯基苯并咪唑并[4,5-f][1,10]邻菲咯啉)及其钌(II)多吡啶配合物[Ru(bpy)2ODCIP]2＋. 运用元素分析、红外光谱、核磁谱和质谱对配体及配合物进行结构表征. 利用紫外吸收光谱、荧光光谱和粘度法研究了[Ru(bpy)2ODCIP]2＋与DNA(脱氧核糖核酸)的作用机制、与Co2＋配位后与DNA的作用机制及其荧光变化情况. 结果表明[Ru(bpy)2ODCIP]2＋与DNA通过部分插入模式作用, [Ru(bpy)2ODCIP]2＋与Co2＋配位形成的双核配合物[Ru(bpy)2(ODCIP)Co]4＋也能与DNA插入结合. 进一步利用稳态荧光发射光谱、荧光淬灭实验等方法研究了单核配合物[Ru(bpy)2ODCIP]2＋和双核配合物[Ru(bpy)2(ODCIP)Co]4＋的荧光性质.     

钌配合物[Ru(bpy)2(PNT)]2+的合成、表征及与DNA相互作用研究

以cis-Ru(bpy)2Cl2·2H2O与PNT为原料合成钌(Ⅱ)多吡啶配合物[Ru(bpy)2(PNT)]2+(bpy=2,2’-联吡啶, PNT=2-[4’-(5-四唑基)苯基]咪唑-[4,5-f][1,10]邻菲咯啉), 通过元素分析、质谱和核磁共振波谱对该化合物进行了结构表征. 利用紫外-可见吸收光谱、荧光光谱、热变性和黏度实验研究了配合物与CT-DNA的相互作用, 实验结果表明, 该配合物以部分插入模式与DNA结合.     

新型双核配合物的形成及荧光性质研究

利用光谱学方法研究了[Ru(bpy)2TPPHZ]2+(TPPHZ=四吡啶[3,2-a: 2',3'-c: 3",2"-h: 2'",3'"-j]吩嗪)和[Ru(bpy)2ODHIP]2+(ODHIP=3,4-二羟基-咪唑并[4,5-f][1,10]邻菲咯啉)与Ni2+的配位情况及配位后的荧光性质变化, 探讨了配合物与Ni2+配位形成双核配合物后与DNA的作用机制变化. 结果表明, [Ru(bpy)2TPPHZ]2+和[Ru(bpy)2ODHIP]2+均可与Ni2+配位, 形成双核配合物[Ru(bpy)2(TPPHZ)Ni]4+和[Ru(bpy)2(ODHIP)Ni]4+, 配合物的荧光强度随着Ni2+浓度的增加而减弱. 与DNA作用后, 配合物仍可与Ni2+配位形成双核配合物, [Ru(bpy)2(TPPHZ)Ni]4+的荧光几乎完全消失, 同时配合物与DNA保持插入模式作用, 而配合物[Ru(bpy)2(ODHIP)Ni]4+与DNA的作用则由沟面结合改为插入结合, 同时配合物的荧光减弱.     

噻吩基钌配合物与酵母RNA的相互作用研究

通过紫外-可见吸收光谱和荧光光谱滴定、稳态荧光猝灭以及盐效应实验研究了噻吩基钌配合物[Ru(bpy)2(Htip)]Cl2(1)、[Ru(Htip)2(dppz)]Cl2(2)、[Ru(Htip)3]Cl2(3)和[Ru2(bpy)4(H2bipt)]Cl4(4){bpy=2,2'-联吡啶;Htip=2-噻吩咪唑[4,5-f][1,10]邻菲咯啉;H2bipt=2,5-二(2-咪唑[4,5-f][1,10]邻菲咯啉)噻吩;dppz=二吡啶并[3,2-a:2',3'-c]吩嗪}与酵母RNA(yeast-RNA)的相互作用,并比较了该类配合物与yeast-RNA和小牛胸腺DNA(ct-DNA)的键合性质。结果表明,该类噻吩基钌配合物是较强的RNA嵌入试剂,其中配合物2和3的RNA键合强度大于其DNA键合强度;此系列配合物在低盐和高盐浓度时均能与RNA较强地结合,即使在100 mmol/L Na Cl条件下仍具有较大的RNA键合常数;配合物1与RNA键合时荧光强度下降,配合物2在水溶液中以及与RNA键合时几乎无荧光,而它们与DNA作用时荧光强度明显增大,显示出良好的区分RNA和DNA的荧光特性。     

吲哚咪唑基钌(Ⅱ)联吡啶配合物与酵母RNA的相互作用

通过紫外-可见光谱和荧光光谱滴定、稳态荧光猝灭和溴化乙啶竞争键合实验研究了Ru(Ⅱ)配合物[Ru(bpy)(H₂iip)₂](ClO₄)₂{bpy=2,2′-联吡啶, H₂iip=2-(吲哚-3-基)-咪唑[4,5-f][1,10]-邻菲罗啉}的酵母RNA键合性质. 结果表明, 二者键合模式为嵌入键合, 其键合常数为7.09×10⁶ L/mol, 比小牛胸腺DNA的键合常数大, 且比同类配合物[Ru(bpy)₂(H₂iip)](ClO₄)₂的酵母RNA键合常数大.     

一个嫁接有羧酸羟基乙基酯的二吡啶吩嗪Ru(II)配合物的合成、与DNA的相互作用以及溶剂变色性质的研究

合成并表征了一个新的Ru(II)配合物[Ru(bpy)₂(hedppc)](ClO₄)₂ {bpy＝2,2'-联吡啶, hedppc＝二联吡啶[3,2-a: 2',3'-c]吩嗪-11-羧酸(2-羟乙基)酯}. 通过紫外-可见吸收光谱、与溴化乙锭竞争实验、粘度测量和DNA裂解实验研究了配合物与小牛胸腺DNA的相互作用性质. 结果表明配合物以插入模式与DNA键合,键合常数K_b＝(6.99±1.34)×10⁶ mol^－1•L (s＝2.03±0.04)与母体配合物[Ru(bpy)₂ (dppz)]^2＋相近,但光致发光和溶剂变色等光学性质与[Ru(bpy)₂ (dppz)]^2＋有明显的差别.     

Ruthenium(II) 2,2'-bibenzimidazole complex as a second-sphere receptor for anions interaction and colorimeter

A ruthenium(II) complex [Ru(bpy) 2(H 2bbim)](PF 6) 2 ( 1) as anions receptor has been exploited, where Ru(II)-bpy moiety acts as a chromophore and the H 2bbim ligand as an anion binding site. A systematic study suggests that 1 interacts with the Cl (-), Br (-), I (-), NO 3 (-), HSO 4 (-), and H 2PO 4 (-) anions via the formation of hydrogen bonds. Whereas 1 undergoes a stepwise process with the addition of F (-) and OAc (-) anions: formation of the monodeprotonated complex [Ru(bpy) 2(Hbbim)] with a low anion concentration, followed by the double-deprotonated complex [Ru(bpy) 2(bbim)], in the presence of a high anion concentration. These stepwise processes concomitant with the changes of vivid colors from yellow to orange brown and then to violet can be used for probing the F (-) and OAc (-) anions by naked eye. The deprotonation processes are not only determined by the basicity of the anion but also related to the strength of hydrogen bonding, as well as the stability of the formed compounds. Moreover, a double-deprotonated complex [Ru(bpy) 2(bbim)].CH 3OH.H 2O ( 3) has been synthesized, and the structural changes induced by the deprotonation has also been investigated. In addition, complexes [Ru(bpy) 2(Hbbim)] 2(HOAc) 3Cl 2.12H 2O ( 2), [Ru(bpy) 2(Hbbim)](HCCl 3CO 2)(CCl 3CO 2).2H 2O ( 4), and [Ru(bpy) 2(H 2bbim)](CF 3CO 2) 2.4H 2O ( 5) have been synthesized to observe the second sphere coordination between the Ru(II)-H 2bbim moiety and carboxylate groups via hydrogen bonds in the solid state.     

Mechanistic implications of proton transfer coupled to electron transfer.

The kinetics of electron transfer for the reactions cis-[Ru(IV)(bpy)2(py)(O)]2+ + H+ + [Os(II)(bpy)3]2+ <==> cis-[Ru(III)(bpy)2(py)(OH)]2+ + [Os(III)(bpy)3]3+ and cis-[Ru(III)(bpy)2(py)(OH)]2+ + H+ + [Os(II)(bpy)3]2+ <==> cis-[Ru(II)(bpy)2(py)(H2O)]2+ + [Os(III)(bpy)3]3+ have been studied in both directions by varying the pH from 1 to 8. The kinetics are complex but can be fit to a double "square scheme" involving stepwise electron and proton transfer by including the disproportionation equilibrium, 2cis-[Ru(III)(bpy)2(py)(OH)]2+ <==> (3 x 10(3) M(-1) x s(-1) forward, 2.1 x 10(5) M(-1) x s(-1) reverse) cis-[Ru(IV)(bpy)2(py)(O)]2+ + cis-[Ru(II)(bpy)2(py)(H2O)]2+. Electron transfer is outer-sphere and uncoupled from proton transfer. The kinetic study has revealed (1) pH-dependent reactions where the pH dependence arises from the distribution between acid and base forms and not from variations in the driving force; (2) competing pathways involving initial electron transfer or initial proton transfer whose relative importance depends on pH; (3) a significant inhibition to outer-sphere electron transfer for the Ru(IV)=O2+/Ru(III)-OH2+ couple because of the large difference in pK(a) values between Ru(IV)=OH3+ (pK(a) < 0) and Ru(III)-OH2+ (pK(a) > 14); and (4) regions where proton loss from cis-[Ru(II)(bpy)2(py)(H2O)]2+ or cis-[Ru(III)(bpy)2(py)(OH)]2+ is rate limiting. The difference in pK(a) values favors more complex pathways such as proton-coupled electron transfer.     

3,6-bis(2'-pyridyl)pyridazine (L) and its deprotonated form (L - H+)- as ligands for {(acac)2Ru(n+)} or {(bpy)2Ru(m+)}: investigation of mixed valency in [{(acac)2Ru}2(mu-L - H+)]0 and [{(bpy)2Ru}2(mu-L - H+)]4+ by spectroelectrochemistry and EPR

Crystallographically characterised 3,6-bis(2'-pyridyl)pyridazine (L) forms complexes with {(acac)2Ru} or {(bpy)2Ru2+}via one pyridyl-N/pyridazyl-N chelate site in mononuclear Ru(II) complexes (acac)2Ru(L), 1, and [(bpy)2Ru(L)](ClO4)2, [3](ClO4)2. Coordination of a second metal complex fragment is accompanied by deprotonation at the pyridazyl-C5 carbon {L --> (L - H+)-} to yield cyclometallated, asymmetrically bridged dinuclear complexes [(acac)2Ru(III)(mu-L - H+)Ru(III)(acac)2](ClO4), [2](ClO4), and [(bpy)2Ru(II)(mu-L - H+)Ru(II)(bpy)2](ClO4)3, [4](ClO4)3. The different electronic characteristics of the co-ligands, sigma donating acac- and pi accepting bpy, cause a wide variation in metal redox potentials which facilitates the isolation of the diruthenium(III) form in [2](ClO4) with antiferromagnetically coupled Ru(III) centres (J = -11.5 cm(-1)) and of a luminescent diruthenium(II) species in [4](ClO4)3. The electrogenerated mixed-valent Ru(II)Ru(III) states 2 and [4]4+ with comproportionation constants Kc > 10(8) are assumed to be localised with the Ru(III) ion bonded via the negatively charged pyridyl-N/pyridazyl-C5 chelate site of the bridging (L - H+)- ligand. In spectroelectrochemical experiments they show similar intervalence charge transfer bands of moderate intensity around 1300 nm and comparable g anisotropies (g1-g3 approximatly 0.5) in the EPR spectra. However, the individual g tensor components are distinctly higher for the pi acceptor ligated system [4]4+, signifying stabilised metal d orbitals.     

The inducing NO-vasodilation by chemical reduction of coordinated nitrite ion in cis-[Ru(NO(2))L(bpy)(2)](+) complex

The synthesis of [Ru(NO(2))L(bpy)(2)](+) (bpy = 2,2'-bipyridine and L = pyridine (py) and pyrazine (pz)) can be accomplished by addition of [Ru(NO)L(bpy)(2)](PF(6))(3) to aqueous solutions of physiological pH. The electrochemical processes of [Ru(NO(2))L(bpy)(2)](+) in aqueous solution were studied by cyclic voltammetry and differential pulse voltammetry. The anodic scan shows a peak around 1.00 V vs. Ag/AgCl attributed to the oxidation process centered on the metal ion. However, in the cathodic scan a second peak around -0.60 V vs. Ag/AgCl was observed and attributed to the reduction process centered on the nitrite ligand. The controlled reduction potential electrolysis at -0.80 V vs. Ag/AgCl shows NO release characteristics as judged by NO measurement with a NO-sensor. This assumption was confirmed by ESI/MS(+) and spectroelectrochemical experiment where cis-[Ru(bpy)(2)L(H(2)O)](2+) was obtained as a product of the reduction of cis-[Ru(II)(NO(2))L(bpy)(2)](+). The vasorelaxation observed in denuded aortic rings pre-contracted with 0.1 mumol L(-1) phenylephrine responded with relaxation in the presence of cis-[Ru(II)(NO(2))L(bpy)(2)](+). The potential of rat aorta cells to metabolize cis-[Ru(II)(NO(2))L(bpy)(2)](+) was also followed by confocal analysis. The obtained results suggest that NO release happens by reduction of cis-[Ru(II)(NO(2))L(bpy)(2)](+) inside the cell. The maximum vasorelaxation was achieved with 1 x 10(-5) mol L(-1) of cis-[Ru(II)(NO(2))L(bpy)(2)](+) complex.     

Mechanism of oxidation of benzaldehyde by polypyridyl oxo complexes of Ru(IV)

The oxidation of benzaldehyde and several of its derivatives to their carboxylic acids by cis-[Ru(IV)(bpy)2(py)(O)]2+ (Ru(IV)=O2+; bpy is 2,2'-bipyridine, py is pyridine), cis-[Ru(III)(bpy)2(py)(OH)]2+ (Ru(III)-OH2+), and [Ru(IV)(tpy)(bpy)(O)]2+ (tpy is 2,2':6',2'-terpyridine) in acetonitrile and water has been investigated using a variety of techniques. Several lines of evidence support a one-electron hydrogen-atom transfer (HAT) mechanism for the redox step in the oxidation of benzaldehyde. They include (i) moderate k(C-H)/k(C-D) kinetic isotope effects of 8.1 +/- 0.3 in CH3CN, 9.4 +/- 0.4 in H2O, and 7.2 +/- 0.8 in D2O; (ii) a low k(H2O/D2O) kinetic isotope effect of 1.2 +/- 0.1; (iii) a decrease in rate constant by a factor of only approximately 5 in CH3CN and approximately 8 in H2O for the oxidation of benzaldehyde by cis-[Ru(III)(bpy)2(py)(OH)]2+ compared to cis-[Ru(IV)(bpy)2(py)(O)]2+; (iv) the appearance of cis-[Ru(III)(bpy)2(py)(OH)]2+ rather than cis-[Ru(II)(bpy)2(py)(OH2)]2+ as the initial product; and (v) the small rho value of -0.65 +/- 0.03 in a Hammett plot of log k vs sigma in the oxidation of a series of aldehydes. A mechanism is proposed for the process occurring in the absence of O2 involving (i) preassociation of the reactants, (ii) H-atom transfer to Ru(IV)=O2+ to give Ru(III)-OH2+ and PhCO, (iii) capture of PhCO by Ru(III)-OH2+ to give Ru(II)-OC(O)Ph+ and H+, and (iv) solvolysis to give cis-[Ru(II)(bpy)2(py)(NCCH3)]2+ or the aqua complex and the carboxylic acid as products.     

双核钌(II)多吡啶配合物与酵母RNA的相互作用研究

用紫外-可见吸收光谱和荧光光谱滴定、稳态荧光淬灭和反向盐滴定实验研究了双核钌(II)配合物[(bpy)₂Ru(ebipcH₂)Ru(bpy)₂](ClO₄)₄ {bpy＝2,2'-联吡啶; ebipcH₂＝N-乙基-4,7-二(咪唑-[4,5-f]-(1,10-邻菲啰啉)-2-基)咔唑}与酵母RNA的相互作用. 结果表明该双核配合物以插入方式与酵母RNA作用, 在生理盐浓度下(≈150 mmol/L NaCl)该配合物与RNA的相互作用明显强于DNA.